Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 The management of chemotherapy-induced nausea and vomiting.

Literature DB >> 3546981

The management of chemotherapy-induced nausea and vomiting.

R J Gralla, L B Tyson, M G Kris, R A Clark.

Abstract

This paper reviews one of the major side-effects of chemotherapy, emesis. Included are patient and treatment factors that can affect the control of nausea and vomiting as well as a summary of the management of chemotherapy-induced emesis.

Entities: Disease Species

Mesh：

Substances：

Year: 1987 PMID： 3546981 DOI： 10.1016/s0025-7125(16)30871-9

Source DB: PubMed Journal: Med Clin North Am ISSN： 0025-7125 Impact factor: 5.456

Keyword Cloud
Cited

13 in total

Review 1. Adverse effects of cancer chemotherapy. An overview of techniques for avoidance/minimisation.

Authors: M Nicolson; R C Leonard
Journal: Drug Saf Date: 1992 Sep-Oct Impact factor: 5.606

2. Potent antiemetic effects of the new serotonin antagonists.

Authors: K P Ryan; J S Evans
Journal: West J Med Date: 1992-01

Review 3. A systematic review and meta-analysis of intravenous palonosetron in the prevention of chemotherapy-induced nausea and vomiting in adults.

Authors: Zhou Likun; Jing Xiang; Ba Yi; Duan Xin; Zheng Liu Tao
Journal: Oncologist Date: 2011-01-31

4. A double-blind, multicentre comparison of intravenous dolasetron mesilate and metoclopramide in the prevention of nausea and vomiting in cancer patients receiving high-dose cisplatin chemotherapy.

Authors: B Chevallier; P Cappelaere; T Splinter; M Fabbro; J L Wendling; L Cals; G Catimel; M Giovannini; D Khayat; P Bastit; N Claverie
Journal: Support Care Cancer Date: 1997-01 Impact factor: 3.603

Review 5. Consensus proposals for the prevention of acute and delayed vomiting and nausea following high-emetic-risk chemotherapy.

Authors: Mark G Kris; Paul J Hesketh; Jorn Herrstedt; Cynthia Rittenberg; Lawrence H Einhorn; Steven Grunberg; Jim Koeller; Ian Olver; Sussanne Borjeson; Enzo Ballatori
Journal: Support Care Cancer Date: 2004-11-23 Impact factor: 3.603

6. A dose-finding study of granisetron, a novel antiemetic, in patients receiving high-dose cisplatin. Granisetron Study Group.

Authors: M Soukop
Journal: Support Care Cancer Date: 1994-05 Impact factor: 3.603

7. Randomized double-blind comparison of three dose levels of intravenous ondansetron in the prevention of cisplatin-induced emesis.

Authors: S M Grunberg; M Lane; E P Lester; K S Sridhar; J Mortimer; W Murphy; P E Sanderson
Journal: Cancer Chemother Pharmacol Date: 1993 Impact factor: 3.333